| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 |
|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Current assets: | |||||||||
Cash and cash equivalents | |||||||||
61,232 | 33,774 | 23,621 | 21,371 | 7,181 | 7,042 | 22,856 | 51,353 | 135,705 | 53,349 |
Marketable securities | |||||||||
15,111 | 57,699 | 93,641 | 111,425 | 135,910 | 100,986 | - | - | - | - |
Marketable securities | |||||||||
- | - | - | - | - | - | 92,522 | 74,570 | - | - |
Prepaid expenses | |||||||||
1,237 | 1,707 | 3,998 | 3,270 | 1,563 | 1,491 | 1,621 | 2,398 | 986 | 792 |
Deferred offering costs | |||||||||
- | - | - | - | - | - | - | - | - | 929 |
Other current assets | |||||||||
1 | 73 | 21 | 22 | 24 | 15 | 24 | 51 | 154 | 84 |
Total current assets | |||||||||
77,581 | 93,253 | 121,281 | 136,088 | 144,678 | 109,534 | 117,023 | 128,372 | 136,845 | 55,154 |
Restricted cash | |||||||||
245 | 245 | 245 | 245 | 84 | 84 | 84 | 84 | 84 | 0 |
Property and equipment, net | |||||||||
380 | 414 | 437 | 325 | 318 | 321 | 319 | 324 | 316 | 39 |
Total assets | |||||||||
78,206 | 93,912 | 121,963 | 136,658 | 145,080 | 109,939 | 117,426 | 128,780 | 137,245 | 55,193 |
Liabilities and stockholders’ equity | |||||||||
Current liabilities: | |||||||||
Accounts payable | |||||||||
1,210 | 6,716 | 9,973 | 8,242 | 3,364 | 2,989 | 4,201 | 4,523 | 1,480 | 1,515 |
Accrued liabilities | |||||||||
1,355 | 5,483 | 2,220 | 1,464 | 1,245 | 2,727 | 3,363 | 6,568 | 4,854 | 3,987 |
Funding advance | |||||||||
- | - | - | - | - | - | 500 | 500 | 500 | - |
Total current liabilities | |||||||||
2,565 | 12,199 | 12,193 | 9,706 | 4,609 | 5,716 | 8,064 | 11,591 | 6,834 | 5,502 |
Other liabilities | |||||||||
24 | 15 | 6 | 11 | 15 | 19 | 22 | 25 | 28 | - |
Total liabilities | |||||||||
2,589 | 12,214 | 12,199 | 9,717 | 4,624 | 5,735 | 8,086 | 11,616 | 6,862 | 5,502 |
Commitments and contingencies (see Note 10) | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | - |
Stockholders’ equity: | |||||||||
Preferred stock, $0.0001 par value, 10,000,000 shares authorized as of March 31, 2020 and December 31, 2019; none issued and outstanding as of March 31, 2020 and December 31, 2019 | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | - |
Common stock, $0.0001 par value, 150,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 36,445,751 and 36,444,732 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively | |||||||||
4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 1 |
Additional paid-in capital | |||||||||
236,751 | 235,777 | 234,893 | 227,561 | 222,882 | 175,635 | - | - | - | - |
Additional paid-in capital | |||||||||
- | - | - | - | - | - | 175,049 | 174,420 | 174,018 | 1,849 |
Accumulated deficit | |||||||||
-161,170 | -154,132 | -125,242 | -100,794 | -82,462 | -71,393 | -65,636 | -57,229 | -43,638 | -33,779 |
Accumulated other comprehensive income | |||||||||
32 | 49 | 109 | 170 | 32 | -41 | -76 | -30 | - | - |
Total stockholders’ equity | |||||||||
75,617 | 81,698 | 109,764 | 126,941 | 140,456 | 104,204 | 109,340 | 117,164 | 130,383 | -31,929 |
Total liabilities and stockholders’ equity | |||||||||
78,206 | 93,912 | 121,963 | 136,658 | 145,080 | 109,939 | 117,426 | 128,780 | 137,245 | 55,193 |
Series A Redeemable Convertible Preferred Stock | |||||||||
Redeemable convertible preferred stock | |||||||||
- | - | - | - | - | - | - | - | - | 41,674 |
Series B Redeemable Convertible Preferred Stock | |||||||||
Redeemable convertible preferred stock | |||||||||
- | - | - | - | - | - | - | - | - | 39,946 |